Catalyst
Slingshot members are tracking this event:
Clovis (CLVS) Expects ARIEL3 Pivotal Maintenance Study Data in Mid-2017 Evaluating Rucaparib in Ovarian Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CLVS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 23, 2017
Occurred Source:
http://ir.clovisoncology.com/phoenix.zhtml?c=247187&p=irol-newsArticle&ID=2275838
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ariel3, Pivotal Maintenance Study, Rucaparib, Ovarian Cancer
